ÂÜÀòÂÒÂ×

Ken Horne is an accomplished professional in the biotechnology and venture capital sectors, currently serving as Managing Partner at AN Venture Partners and Chief Executive Officer at Typewriter Therapeutics, Inc. and Capacity Bio. Horne has held significant leadership roles including President at Viage Therapeutics, Inc. and has been an advisor at Kicker Ventures and Preferred Medicine, Inc. Moreover, Horne played a key role as Chairperson at RDiscovery, focusing on the establishment of cross-border biotech companies. Horne's academic background includes a Master's and Bachelor's degree in Biomechanical Engineering from Stanford University.